Showing results (1-10 of 446) with videos related to
Sort By:
Pageof 45
Drug Safety|September 8, 2004
Quantifying adverse drug events : are systematic reviews the answer?Mahyar Etminan, Bruce Carleton, Paula A RochonPharmacotherapy|March 14, 2019
Risk of Gynecomastia with Users of Proton Pump InhibitorsBonnie He, Bruce Carleton, Mahyar EtminanPharmacotherapy|November 19, 2003
Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adultsMahyar Etminan, David L Streiner, Paula A RochonThe Pediatric Infectious Disease Journal|May 31, 2018
Oral Fluoroquinolone Prescribing to Children in the United States From 2006 to 2015Mahyar Etminan, Michael Y Guo, Bruce CarletonJournal of Child and Adolescent Psychopharmacology|August 20, 2015
Risperidone and Risk of Gynecomastia in Young MenMahyar Etminan, Bruce Carleton, James M BrophyDrug Safety|May 22, 2002
Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysisBahi Takkouche, Mahyar Etminan, Francisco Caamaño, et al.Neurology|July 30, 2017
Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control studyMohit Sodhi, Claire A Sheldon, Bruce Carleton, et al.BMC Pulmonary Medicine|September 6, 2012
Beta-blocker use and COPD mortality: a systematic review and meta-analysisMahyar Etminan, Siavash Jafari, Bruce Carleton, et al.The American Journal of Medicine|May 30, 2002
Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysisMahyar Etminan, Mitchell A H Levine, George Tomlinson, et al.Pharmacotherapy|March 26, 2004
Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trialsMahyar Etminan, Bruce Carleton, J A C Delaney, et al.Pageof 45